Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Perkins Tandra CDirector | Grant or award | A | $1,125 14 sh | Feb 4, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 7,019 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Link David ForrestDirector | Grant or award | A | — 771 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,474 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Grant or award | A | — 5,673 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Regan John PSEVP, Chief Risk Officer | Tax withholding | F | $23K 1,835 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 44.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 238.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Shaikh KashifDirector, President and CEO | Grant or award | A | — 238.2K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 6,485 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Bohen SeanDirector, PRESIDENT AND CEO | Grant or award | A | — 850.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Monroe CarolynSVP - Title Insurance | Option exercise | M | — 16.5K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Go WilliamChief Medical Officer | Grant or award | A | — 154.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Biebuyck OlivierPresident, Fab Tech | Option exercise | M | — 1,232 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Pfeiffenberger BrentDirector, President and CEO | Grant or award | A | — 475.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 2,110 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $102K 9,280 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Stiles Spencer SPresident and COO | Option exercise | M | — 13.8K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 9 | Ghingo John FDirector, President | Grant or award | A | — 201.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Peterson Timothy GeorgeEVP Chf Cust & Tech Officer | Grant or award | A | — 11.3K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Kleczynski Robert ASVP, Controller & Tax | Option exercise | M | — 1,684 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 24.7K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Jones Jeanne MEVP, CFO, Audit & Risk | Option exercise | M | — 5,197 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Honorable Colette DEVP CLO Compliance & Corp Sec | Grant or award | A | — 12.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Honorable Colette DEVP CLO Compliance & Corp Sec | Option exercise | M | — 3,872 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Adamchak MarkPrincipal Accounting Officer | Grant or award | A | — 10.9K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Bachrodt AmySVP, Finance | Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Fox-Geen JeremyChief Financial Officer | Tax withholding | F | $248K 3,877 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $61K 2,970 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Allaire JeremyDirector, Chairman and CEO | Tax withholding | F | $537K 8,404 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $51K 2,492 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Gummadi SuryaPresident - Americas | Open-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Allaire JeremyDirector, Chairman and CEO | Option exercise | M | — 2,434 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 6 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 5 | Bharucha DavidChief Medical Officer | Grant or award | A | — 204.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Chuang Patrick T.Senior VP, Memory Design | Grant or award | A | — 20.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Saldanha CraigChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |